(Q41443197)

30 September 2017

1 reference

title

Congestive heart failure and arrhythmias: therapeutic modalities (English)

1 reference

30 September 2017

main subject

congestive heart failure

1 reference

Singh SN

1

1 reference

30 September 2017

publication date

1 January 1997

1 reference

Journal of Cardiovascular Electrophysiology

30 September 2017

published in

1 reference

30 September 2017

volume

8

1 reference

30 September 2017

issue

1

1 reference

30 September 2017

page(s)

89-97

1 reference

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB00613.X

Stretch-induced arrhythmias in the isolated canine ventricle. Evidence for the importance of mechanoelectrical feedback

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB00613.X

The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB00613.X

Long-term effect of mexiletine on left ventricular function and relation to suppression of ventricular arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB00613.X

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB00613.X

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB00613.X

Negative lusitropic effect of DPI 201-106 and E4031. Possible role of prolonging action potential duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB00613.X

Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB00613.X

Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB00613.X

Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB00613.X

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB00613.X

Psychosocial risk factors and nonfatal myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB00613.X

Infarct artery patency predicts outcome of serial electropharmacological studies in patients with malignant ventricular tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB00613.X

10.1111/J.1540-8167.1997.TB00613.X

21 January 2018

Identifiers

DOI

1 reference

30 September 2017

1 reference